Targeted therapeutics for colon cancer to be presented at AACR meeting
Anurag Singh, PhD, assistant professor in the Department of Pharmacology and Experimental Therapeutics at Boston University School of Medicine has been invited to present his recent work on targeted therapeutics for colon ...
Cancer
Apr 04, 2012 |
not rated yet |
0
New drug prevents spread of human prostate cancer cells
A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the ...
Cancer
Apr 03, 2012 |
5 / 5 (2) |
0
Two specific agents worse than one in treating endocrine resistant breast cancer cells
A new class of agents known as c-Src inhibitors is being tested in a number of different ways to treat breast cancer, but researchers at Georgetown Lombardi Comprehensive Cancer Center caution that they should not be used ...
Cancer
Apr 02, 2012 |
not rated yet |
0
PI3K/mTOR pathway proteins tied to poor prognosis in breast cancer
Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR ...
Cancer
Apr 01, 2012 |
not rated yet |
0
Two targeted therapies act against Ewing's sarcoma tumors
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson ...
Cancer
Apr 01, 2012 |
5 / 5 (1) |
0
|
Researchers identify mechanism that makes breast cancer invasive
A new study has identified a key mechanism that causes breast cancer to spread. The research, published by Cell Press on March 30th in the journal Molecular Cell, enhances our knowledge about the signals that drive cancer ...
Cancer
Mar 29, 2012 |
not rated yet |
0
The path to personalized cancer treatment
In the largest study of its kind, researchers have profiled genetic changes in cancer with drug sensitivity in order to develop a personalised approach to cancer treatments. The study is published in Nature on Thursday 29 Mar ...
Cancer
Mar 28, 2012 |
5 / 5 (2) |
0
|
Protein found to regulate spread of pancreatic cancer cells
Researchers at Queen Mary, University of London have identified a new protein that makes pancreatic cancer cells less 'sticky' and therefore less able to attach to and invade other tissue.
Cancer
Mar 26, 2012 |
5 / 5 (2) |
0
|
Study role testosterone may play in triple negative breast cancer
Could blocking a testosterone receptor lead to a new way to treat an aggressive form of breast cancer? That's a question researchers at Mayo Clinic in Arizona and the Translational Genomics Research Institute (TGen) are exploring. ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
|
Study: Preoperative estrogen-blocking therapy may preempt need for mastectomy
Preoperative treatment with aromatase inhibitors increases the likelihood that postmenopausal women with estrogen receptor-positive breast cancer will be able to have breast-conserving surgery rather than a mastectomy, according ...
Cancer
Mar 23, 2012 |
5 / 5 (1) |
0
Study may lead to new treatments for prostate cancer
A recent study conducted at Marshall University may eventually help scientists develop new treatments for prostate cancer, the most common malignancy in American men.
Cancer
Mar 21, 2012 |
not rated yet |
0
BRG1 mutations confer resistance to hormones in lung cancer
Retinoic acid (vitamin A) and steroids are hormones found in our body that protect against oxidative stress, reduce inflammation and are involved in cellular differentiation processes. One of the characteristics of tumours ...
Cancer
Mar 15, 2012 |
not rated yet |
0
Bright future ahead for antibody cancer therapy
Antibodies, once touted as the "magic bullets" of cancer care, are now fulfilling that promise and more advances are on the way, say cancer researchers at the Georgetown Lombardi Comprehensive Cancer Center
Cancer
Mar 15, 2012 |
5 / 5 (4) |
0
|
Clot-busting enzyme plays 'peek-a-boo' with blood clots
By discovering how a blood clot-busting enzyme is switched on, researchers have unlocked a century-old atomic riddle that could lead to new treatments for clotting and bleeding disorders, and some cancers.
Medical research
Mar 08, 2012 |
5 / 5 (2) |
0
|
Researchers develop first 'theranostic' treatment for acute lymphoblastic leukemia (ALL)
A team of researchers at Case Western Reserve University School of Medicine has developed the first "theranostic" agent for the treatment of acute lymphoblastic leukemia (ALL). ALL is the most common type of childhood cancer ...
Cancer
Mar 07, 2012 |
5 / 5 (2) |
0
|
